title: [S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"].
abstract: This guideline updates a prior concensus recommendation of the German Society for Digestive and Metabolic Diseases (DGVS) from 1996. It was developed by an interdisciplinary cooperation with representatives of the German Society for Microbiology, the Society for Pediatric Gastroenterology and Nutrition (GPGE) and the German Society for Rheumatology. The guideline is methodologically based on recommendations of the Association of the Scientific Medical Societies in Germany (AWMF) for providing a systematic evidence-based consensus guideline of S 3 level and has also implemented grading criteria according to GRADE (Grading of Recommendations Assessment, Development and Evaluation). Clinical applicability of study results as well as specifics for Germany in terms of epidemiology, antibiotic resistance status, diagnostics and therapy were taken into account.
authors.affiliation: Medizinische Klinik II, Klinikum Aschaffenburg, Akad. Lehrkrankenhaus der Universität Würzburg, Aschaffenburg. med2-aschaffenburg@t-online.de
authors.forename: W
authors.initials: W
authors.lastname: Fischbach
authors.forename: P
authors.initials: P
authors.lastname: Malfertheiner
authors.forename: J C
authors.initials: JC
authors.lastname: Hoffmann
authors.forename: W
authors.initials: W
authors.lastname: Bolten
authors.forename: J
authors.initials: J
authors.lastname: Bornschein
authors.forename: O
authors.initials: O
authors.lastname: Götze
authors.forename: W
authors.initials: W
authors.lastname: Höhne
authors.forename: M
authors.initials: M
authors.lastname: Kist
authors.forename: S
authors.initials: S
authors.lastname: Koletzko
authors.forename: J
authors.initials: J
authors.lastname: Labenz
authors.forename: P
authors.initials: P
authors.lastname: Layer
authors.forename: St
authors.initials: S
authors.lastname: Miehlke
authors.forename: A
authors.initials: A
authors.lastname: Morgner
authors.forename: U
authors.initials: U
authors.lastname: Peitz
authors.forename: J C
authors.initials: JC
authors.lastname: Preiss
authors.forename: C
authors.initials: C
authors.lastname: Prinz
authors.forename: U
authors.initials: U
authors.lastname: Rosien
authors.forename: W E
authors.initials: WE
authors.lastname: Schmidt
authors.forename: A
authors.initials: A
authors.lastname: Schwarzer
authors.forename: S
authors.initials: S
authors.lastname: Suerbaum
authors.forename: A
authors.initials: A
authors.lastname: Timmer
authors.forename: G
authors.initials: G
authors.lastname: Treiber
authors.forename: M
authors.initials: M
authors.lastname: Vieth
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D002648:Child; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005753:Gastric Mucosa / Q000382:microbiology / Q000473:pathology; D005773:Gastroscopy; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D016480:Helicobacter pylori; D006801:Humans; D016393:Lymphoma, B-Cell / Q000473:pathology / Q000517:prevention & control; D018442:Lymphoma, B-Cell, Marginal Zone / Q000473:pathology / Q000517:prevention & control; D009367:Neoplasm Staging; D010437:Peptic Ulcer / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000473:pathology / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents